Article Details

Gilead's Remdesivir Delivered Orally in Capsule Could Reduce COVID Hospitalizations ...

Retrieved on: 2021-08-25 11:48:45

Tags for this article:

Click the tags to see associated articles and topics

Gilead's Remdesivir Delivered Orally in Capsule Could Reduce COVID Hospitalizations .... View article details on hiswai:

Excerpt

The FDA has approved the use of remdesivir only for adults and children age 12 and older. The researchers have described cell and animal studies that ...

Article found on: www.hospimedica.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up